Answer
After a single 300 mg oral dose, niraparib, the active drug in Zejula, had a mean terminal half-life ranging from 44 to 54 hours (approximately 2 days) across studies.
Sources for this answer
- Zejula 100mg TabletsGlaxoSmithKline UK · emc · SmPC §5.2 Pharmacokinetic properties · Version 9Document updated
Sources checked